DEA

DEA Designates Propionyl Chloride as List I Chemical

The DEA has finalized a rule designating propionyl chloride as a List I chemical under the Controlled Substances Act. This action subjects handlers of propionyl chloride to regulatory provisions due to its use in the illicit manufacture of fentanyl and its analogues. The rule becomes effective on April 9, 2026.

DEA Notice: Stepan Company Application for Bulk Controlled Substance Manufacturer

The DEA has published a notice regarding Stepan Company's application to be registered as a bulk manufacturer of cocaine and ecgonine. Interested parties can submit comments or requests for a hearing by May 12, 2026.

DEA Notice: Lonza Tampa LLC Application for Controlled Substance Importer Registration

The DEA has published a notice regarding an application from Lonza Tampa, LLC to be registered as an importer of psilocybin (Schedule I controlled substance). Interested parties can submit comments or requests for a hearing by April 13, 2026.

DEA Notice: Patheon API Services Controlled Substance Application

The DEA has published a notice regarding an application from Patheon API Services Inc. to be registered as a bulk manufacturer of controlled substances, including Dimethyltryptamine, Psilocybin, Psilocyn, Amphetamine, and Methadone. Interested parties can submit comments or requests for a hearing by May 12, 2026.

DEA Announces 10,744 Arrests in DC Safety Initiative

The Drug Enforcement Administration (DEA) announced 10,744 arrests as part of an initiative to enhance safety in Washington D.C. The operation involved collaboration between local and federal law enforcement agencies, with the goal of removing illicit substances from communities.

DEA Reports 10,712 Arrests and Reduced Drug Availability

The DEA announced 10,712 arrests and a reduction in drug availability on the streets of Washington, D.C. This enforcement action, in coordination with other law enforcement agencies, aims to improve public safety and reduce crime.

DEA Seizes $600,000 from Semi-Truck Driver

The DEA Houston Division announced the seizure of over $600,000 from a semi-truck driver suspected of transporting funds for Mexican cartels. The seizure was a joint effort with the Department of Homeland Security (DHS).

DEA Schedules Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I

The Drug Enforcement Administration (DEA) is permanently scheduling five substances (clonazolam, diclazepam, etizolam, flualprazolam, and flubromazolam) in Schedule I of the Controlled Substances Act. This rule is effective April 1, 2026.

DEA Rule: Registering Emergency Medical Services Agencies

The Drug Enforcement Administration (DEA) has issued a final rule requiring Emergency Medical Services (EMS) agencies to register and handle controlled substances. This rule implements provisions of the Protecting Patient Access to Emergency Medications Act of 2017 and takes effect on March 9, 2026.